Decreased Intoxication by Fluorouracil When Slowly Administered in Glucose
- 28 September 1963
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 185 (13) , 1012-1016
- https://doi.org/10.1001/jama.1963.03060130030009
Abstract
Moderate to severe systemic intoxication resulting from rapid intravenous injection of 5-fluorouracil in cancer chemotherapy has been reduced from an incidence of 50% to 60% to 6% in a series of 83 patients by use of infusions in 5% glucose over 8 hours. Doses of 10 to 25 gm per patient per course have been tolerated with minimal toxic reactions. There was objective palliation of metastases in 27% from drug therapy alone, and in a further 10% by treatment combined with hormonal or x-ray therapy. Avoidance of intoxication by slow intravenous infusion has broadened the opportunities for use of this drug in ambulatory therapy of colorectal, biliary tract, ovarian, and mammary cancer.Keywords
This publication has 10 references indexed in Scilit:
- VARIOUS METHODS OF ADMINISTERING 5-FLUOROURACIL1962
- Increased sensitivity of the Walker tumour towards aromatic nitrogen mustards carrying basic side chains following glucose pretreatmentBiochemical Pharmacology, 1961
- A method of labeling tissues with tritiated thymidine in vitro and its use in comparing rates of cell proliferation in duct epithelium, fibroadenoma, and carcinoma of human breastCancer, 1961
- Chemotherapy of human solid tumors with 5-fluorouracilCancer, 1960
- Evaluation of 5-Fluorouracil in the Treatment of CancerJNCI Journal of the National Cancer Institute, 1960
- STUDIES ON FLUORINATED PYRIMIDINES .10. INVIVO STUDIES ON TUMOR RESISTANCE1960
- THE CLINICAL EFFECTS OF THE CONTINUOUS ADMINISTRATION OF FLUORINATED PYRIMIDINES (5-FLUOROURACIL AND 5-FLUORO-2]-DEOXYURIDINE)1960
- REDUCTION OF 5-FLUOROURACIL TOXICITY IN MAN WITH RETENTION OF ANTICANCER EFFECTS BY PROLONGED INTRAVENOUS ADMINISTRATION IN 5-PERCENT DEXTROSE1960
- Further Clinical Studies With 5-Fluorouracil23JNCI Journal of the National Cancer Institute, 1959
- CLINICAL STUDY OF 5-FLUOROURACIL1959